|
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
|
D060426 |
[Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.
] |
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
|
D056648 |
[Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.
] |
|
Anti-Obesity Agents
|
D019440 |
[Agents that increase energy expenditure and weight loss by neural and metabolic regulation.
] |
|
Anti-Retroviral Agents
|
D044966 |
[Agents used to treat RETROVIRIDAE INFECTIONS.
] |
|
Anti-Ulcer Agents
|
D000897 |
[Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
] |
|
Anti-Vaccination Movement
|
D000070377 |
[Group activities directed against VACCINATION.
] |
|
Antiaris
|
D031621 |
[A plant genus of the family MORACEAE. Members have been used as an arrow poison.
] |
|
Antibiosis
|
D000898 |
[A natural association between organisms that is detrimental to at least one of them. This often refers to the production of chemicals by one microorganism that is harmful to another.
] |
|
Antibiotic Prophylaxis
|
D019072 |
[Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications.
] |
|
Antibiotics, Antineoplastic
|
D000903 |
[Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
] |
|
Antibiotics, Antitubercular
|
D000904 |
[Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.
] |
|
Antibodies
|
D000906 |
[Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
] |
|
Antibodies, Anti-Idiotypic
|
D000888 |
[Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
] |
|
Antibodies, Anticardiolipin
|
D017153 |
[Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN.
] |
|
Antibodies, Antineutrophil Cytoplasmic
|
D019268 |
[Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
] |
|
Antibodies, Antinuclear
|
D000974 |
[Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.
] |
|
Antibodies, Antiphospholipid
|
D017152 |
[Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.
] |
|
Antibodies, Archaeal
|
D019844 |
[Immunoglobulins produced in a response to ARCHAEAL ANTIGENS.
] |
|
Antibodies, Bacterial
|
D000907 |
[Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
] |
|
Antibodies, Bispecific
|
D018033 |
[Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.
] |
